CoChat

Exploitation of a novel phenothiazine derivative for its anti-cancer activities in malignant glioblastoma

The DOI matches its Crossref record; 80 of the 81 references it cites were found in a registry or an index.

Abstract

Glioblastoma remains the most malignant of all primary adult brain tumours with poor patient survival and limited treatment options. This study adopts a drug repurposing approach by investigating the anti-cancer activity of a derivative of the antipsychotic drug phenothiazine (DS00329) in malignant U251 and U87 glioblastoma cells. Results from MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) and clonogenic assays showed that DS00329 inhibited short-term glioblastoma cell viability and long-term survival while sparing non-cancerous cells. Western blot analysis with an antibody to γH2AX showed that DS00329 induced DNA damage and flow cytometry and western blotting confirmed that it triggered a G1 cell cycle arrest which correlated with decreased levels in Cyclin A, Cyclin B, Cyclin D1 and cyclin dependent kinase 2 and an increase in levels of the cyclin dependent kinase inhibitor p21. DS00329 treated glioblastoma cells exhibited morphological and molecular markers typical of apoptotic cells such as membrane blebbing and cell shrinkage and an increase in levels of cleaved PARP. Flow cytometry with annexin V-FITC/propidium iodide staining confirmed that DS00329 induced apoptotic cell death in glioblastoma cells. We also show that DS00329 treatment of glioblastoma cells led to an increase in the autophagosome marker LC3-II and autophagy inhibition studies using bafilomycin A1 and wortmannin, showed that DS00329-induced-autophagy was a pro-death mechanism. Further…

Overview

Integrity signals

Registry

Crossref · 10.1007/s10495-020-01594-5

Cites

80 of 80 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

1 retracted

Show all 80 references

Research works printed but not linked: 1

  1. Gupta R (1988) Bioactive molecules: phenothiazine and 1, 4-benzothiazines, Chemical and Biological Aspects, vol 4. Elsevier, Amsterdam

Cited by

See all 58

Metadata

Authors
Omoruyi, S. I., Ekpo, O. E., Semenya, D. M., Jardine, A., & Prince, S.
Affiliations
  • University of Cape Town (ZA)
  • University of the Western Cape (ZA)
Corresponding author
Prince, S.
Venue
Apoptosis
Published
2020-02-08
Volume
25
Issue
3-4
Pages
261-274
ISSN
  • 1360-8185 (ISSN-L)
  • 1573-675X
OpenAlex
W3004606969
Cited by
53
References
81
Citations by year
2026: 7 · 2025: 11 · 2024: 9 · 2023: 6 · 2022: 10 · 2021: 6 · 2020: 4
FWCI
3.36
Type
journal article
Language
en
Open access
closed
Licence
Locations
  • APOPTOSIS (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Oncology › Glioma Diagnosis and Treatment
  • Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Toxicology › Bioactive Compounds and Antitumor Agents
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer Mechanisms and Therapy
Keywords
glioblastoma, phenothiazines, drug repurposing, antipsychotic drugs, autophagy, G1 cell cycle arrest, DNA damage, PI3K/Akt signaling, p21, U251 cells, U87 cells, anticancer activity
MeSH terms
Antineoplastic Agents, Autophagy, Cell Cycle, Cell Survival, DNA Damage, Glioblastoma, Humans, Phenothiazines, Signal Transduction, Apoptosis, Phosphatidylinositol 3-Kinases, Cell Line, Tumor, Cell Proliferation, Proto-Oncogene Proteins c-akt, Drug Repositioning

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Exploitation of a novel phenothiazine derivative for its anti-cancer activities in malignant glioblastoma. https://app.cochat.ai/papers/10.1007/s10495-020-01594-5
The paper
Omoruyi, S. I., Ekpo, O. E., Semenya, D. M., Jardine, A., & Prince, S. (2020). Exploitation of a novel phenothiazine derivative for its anti-cancer activities in malignant glioblastoma. Apoptosis. https://doi.org/10.1007/s10495-020-01594-5

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.